Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities

Published:2021-09 Issue:3 Volume:127 Page:354-362.e2
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Casale Thomas,Molfino Nestor A.,Silver Jared,Bogart Michael,Packnett Elizabeth,McMorrow Donna,Wu Joanne,Hahn Beth

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference55 articles.

1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014

2. Real-world effectiveness of mepolizumab in patients with severe asthma: an examination of exacerbations and costs;Llanos;J Asthma Allergy,2020

3. Characterization of severe asthma worldwide: data from the international severe asthma registry;Wang;Chest,2020

4. Managing comorbid conditions in severe asthma;Bardin;Med J Aust,2018

5. Impact of mepolizumab on exacerbations in severe asthma: results from a U.S. insurance claims data base;Ortega;Allergy Asthma Proc,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Effectiveness of Benralizumab Among Patients with Asthma and Concomitant Chronic Obstructive Pulmonary Disease;International Journal of Chronic Obstructive Pulmonary Disease;2024-08

2. Real-world unified airway benefits of mepolizumab;Annals of Allergy, Asthma & Immunology;2024-07

3. Comparative Impact of Asthma Biologics: A Nationwide US Claim-Based Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

4. Advancements in biologic therapy in eosinophilic asthma;Expert Opinion on Biological Therapy;2024-04-02

5. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study;2024-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3